MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma

Pancreatic cancer is the fourth leading cause of cancer death in western countries with more than 100,000 new cases per year in Europe and a mortality rate higher than 90%. In this scenario, advanced therapies based on gene therapies are emerging, thanks to a better understanding of tumour architect...

Descripción completa

Detalles Bibliográficos
Autores principales: Rossignoli, Filippo, Spano, Carlotta, Grisendi, Giulia, Foppiani, Elisabetta Manuela, Golinelli, Giulia, Mastrolia, Ilenia, Bestagno, Marco, Candini, Olivia, Petrachi, Tiziana, Recchia, Alessandra, Miselli, Francesca, Rovesti, Giulia, Orsi, Giulia, Veronesi, Elena, Medici, Gregorio, Petocchi, Benedetta, Pinelli, Massimo, Horwitz, Edwin M., Conte, Pierfranco, Dominici, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2019
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376176/
https://www.ncbi.nlm.nih.gov/pubmed/30809285
http://dx.doi.org/10.7150/thno.27576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376176/
https://www.ncbi.nlm.nih.gov/pubmed/30809285
http://dx.doi.org/10.7150/thno.27576

Ejemplares similares